Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07407894 · ClinicalTrials.gov registry record · NA

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

A NA study of Healthy Aging and Anti Aging, sponsored by Synbiotic Health.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT07407894 is a NA study of Healthy Aging and Anti Aging that is actively recruiting participants, run by Synbiotic Health. The registered enrollment target is 80 participants, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07407894, a NA study of Healthy Aging and Anti Aging, is actively recruiting participants, sponsored by Synbiotic Health.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Bifidobacterium adolescentis iVS-1

Study Locations (1)

Florida

  • MusB Research LLC - New Port Richey

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-02
Est. Completion 2027-01
Phase NA

Sponsor

Synbiotic Health

3 total trials

What the Registry Record Tells You About NCT07407894

The ClinicalTrials.gov registry entry for NCT07407894 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (33% lower). The listed sponsor is Synbiotic Health, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07407894 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07407894 about?

NCT07407894 is a clinical study titled "iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults". This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation ...

What is the current status of trial NCT07407894?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-02. Estimated completion is 2027-01.

What conditions does trial NCT07407894 study?

This clinical trial studies the following conditions: Healthy Aging, Anti Aging.

What interventions are being tested in trial NCT07407894?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Bifidobacterium adolescentis iVS-1 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07407894?

This trial is sponsored by Synbiotic Health, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07407894 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.